MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$5,661M
(-5.19%↓ Y/Y)
Depreciation and
amortization
$1,546M
(10.98%↑ Y/Y)
Net losses on
financial instruments
-$653M
(-46.74%↓ Y/Y)
Share-based compensation
$276M
(44.50%↑ Y/Y)
Policy liabilities
$228M
(112.39%↑ Y/Y)
Impairment of property,
equipment and...
$108M
(4.85%↑ Y/Y)
Other assets
-$57M
(93.08%↑ Y/Y)
Net cash provided by
operating activities
$4,290M
(-26.14%↓ Y/Y)
Canceled cashflow
$4,239M
Change in cash and cash
equivalents
$1,203M
(-34.19%↓ Y/Y)
Canceled cashflow
$3,087M
Receivables, net
$2,526M
(269.84%↑ Y/Y)
Accounts payable and
other liabilities
-$720M
(-164.71%↓ Y/Y)
Equity in net
(earnings) losses of other...
$398M
(39700.00%↑ Y/Y)
Income taxes
-$297M
(-173.51%↓ Y/Y)
Deferred income taxes
-$279M
(25.40%↑ Y/Y)
Unearned income
-$15M
(86.73%↑ Y/Y)
Other, net
$4M
(110.26%↑ Y/Y)
Proceeds from long-term
borrowings, net issuance...
$2,991M
(-61.21%↓ Y/Y)
Proceeds from short-term
borrowings
$1,505M
(447.27%↑ Y/Y)
Changes in bank
overdrafts
$1,312M
(305.64%↑ Y/Y)
Changes in securities
lending payable
$386M
(614.67%↑ Y/Y)
Proceeds from issuance of
common stock under...
$79M
(-64.25%↓ Y/Y)
Other, net
$22M
(1000.00%↑ Y/Y)
Proceeds from sale of
investments
$13,324M
(-19.48%↓ Y/Y)
Maturities, calls and
redemptions from...
$1,771M
(-12.54%↓ Y/Y)
Purchases of
subsidiaries, net of cash...
-$88M
(-101.83%↓ Y/Y)
Net cash provided by
(used in) financing...
-$1,738M
(-245.68%↓ Y/Y)
Net cash used in
investing activities
-$1,344M
(73.99%↑ Y/Y)
Effect of foreign
exchange rates on cash and...
-$5M
(16.67%↑ Y/Y)
Canceled cashflow
$6,295M
Canceled cashflow
$15,183M
Repurchase and retirement
of common stock
$2,605M
(-10.17%↓ Y/Y)
Purchases of investments
$15,026M
(-16.46%↓ Y/Y)
Repayments of long-term
borrowings
$2,147M
(30.12%↑ Y/Y)
Repayments of short-term
borrowings
$1,720M
(1174.07%↑ Y/Y)
Cash dividends
$1,529M
(1.39%↑ Y/Y)
Taxes paid through
withholding of common stock...
$32M
(-70.64%↓ Y/Y)
Purchases of property and
equipment
$1,116M
(-11.15%↓ Y/Y)
Changes in securities
lending collateral
$385M
(627.40%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
Apex-Header-svg
Elevance Health, Inc. (ELV)
Apex-Header-svg
Elevance Health, Inc. (ELV)